Point72 Asset Management »

Arrivent Biopharma shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.4M 217k 20.12
2024-03-31 $516k 29k 17.86

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Amazon (AMZN)
Broadcom (AVGO)
Arista Networks Com Shs (ANET)
Microsoft Corporation (MSFT)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Asml Holding N V N Y Registry Shs (ASML)
Spotify Technology S A SHS (SPOT)
Sea Sponsord Ads (SE)
Biogen Idec (BIIB)
Equinix (EQIX)
Coherent Corp (COHR)

View all positions for Point72 Asset Management

Top funds holding Arrivent Biopharma

Infinitum Asset Management
Suvretta Capital Management
Hillhouse Capital Advisors
FMR
OrbiMed Advisors
BlackRock
Octagon Capital Advisors
Novo A/S
Vanguard Group
Sofinnova Ventures
General Catalyst Group Management
State Street Corporation
Geode Capital Management
Goldman Sachs Group
Sc China Holding

View all funds holding Arrivent Biopharma